Known disorder affecting gastrointestinal absorption
Gastrointestinal disorder affecting absorption or the ability to swallow tablets
Gastrointestinal (GI) disorder that negatively affects absorption
Severe gastrointestinal disorder
Gastrointestinal disorder affecting absorption (e.g., gastrectomy)
Gastrointestinal disorder affecting absorption.
No gastrointestinal (GI) disorder that negatively affects absorption
Gastrointestinal disorder affecting absorption
Gastrointestinal disorder affecting absorption
An active gastrointestinal disorder affecting absorption (e.g., gastrectomy, active peptic ulcer disease, uncontrolled celiac)
Gastrointestinal disorder affecting absorption (e.g., gastrectomy, active peptic ulcer disease within last  months, inflammatory bowel disease)
Gastrointestinal disorder affecting absorption
Gastrointestinal disorder affecting absorption
Gastrointestinal disorder affecting absorption;
Subject has a gastrointestinal disorder affecting absorption.
Any gastrointestinal disorder expected to limit absorption of ibrutinib
Gastrointestinal disorder affecting absorption (e.g., gastrectomy, active peptic ulcer disease within last  months)
No gastrointestinal (GI) disorder that negatively affects absorption
Gastrointestinal disorder affecting absorption (e.g., gastrectomy, active peptic ulcer disease within last  months)
Gastrointestinal disorder affecting absorption (e.g., gastrectomy, active peptic ulcer disease) within last  months
Gastrointestinal disorder affecting absorption (e.g., gastrectomy, active peptic ulcer disease within last  months).
Gastrointestinal disorder affecting absorption.
Any gastrointestinal disorder expected to limit absorption of ibrutinib
Gastrointestinal disorder affecting absorption.
Gastrointestinal disorder affecting absorption.
Gastrointestinal disorder affecting absorption (e.g., gastrectomy, active peptic ulcer disease within last  months)